about
Number concentration and size of particles in urban air: effects on spirometric lung function in adult asthmatic subjectsDeveloping pandemic preparedness in Europe in the 21st century: experience, evolution and next steps.Assessment of human influenza pandemic scenarios in Europe.Observed and projected drivers of emerging infectious diseases in Europe.Initial surveillance of 2009 influenza A(H1N1) pandemic in the European Union and European Economic Area, April-September 2009.Influenza-related deaths--available methods for estimating numbers and detecting patterns for seasonal and pandemic influenza in Europe.Basic Surveillance Network, a European database for surveillance data on infectious diseases.Determinants and Drivers of Infectious Disease Threat Events in EuropeOccurrence of invasive pneumococcal disease and number of excess cases due to influenza.Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria.Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparumIn vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017Highly pathogenic avian influenza A(H5N8) outbreaks: protection and management of exposed people in Europe, 2014/15 and 2016.Human-Dromedary Camel Interactions and the Risk of Acquiring Zoonotic Middle East Respiratory Syndrome Coronavirus Infection.Ultrafine particles in urban air and respiratory health among adult asthmatics.Mortality and air pollution in metropolitan Helsinki, 1988--1996.Source-specific fine particles in urban air and respiratory function among adult asthmatics.Start of the 2014/15 influenza season in Europe: drifted influenza A(H3N2) viruses circulate as dominant subtype.Comparing introduction to Europe of highly pathogenic avian influenza viruses A(H5N8) in 2014 and A(H5N1) in 2005.Influenza season 2013/14 has started in Europe with influenza A(H1)pdm09 virus being the most prevalent subtype.Taking stock of the first 133 MERS coronavirus cases globally--Is the epidemic changing?Letter to the editor: Just a coincidence? Two severe human cases due to swine influenza (SIV) A(H1N1)v in Europe, October 2016Decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines: an observational bias or a technical challenge?Author's reply: Regarding the editorial by Penttinen and Friede.ECDC expert opinion on efficacy and effectiveness of neuraminidase inhibitors published for public consultation.Surveillance and laboratory detection for non-polio enteroviruses in the European Union/European Economic Area, 2016.An outbreak of mumps in Sweden, February-April 2004.A case-cohort study to investigate concomitant waterborne outbreaks of Campylobacter and gastroenteritis in Söderhamn, Sweden, 2002-3.Influenza case definitions - optimising sensitivity and specificity.[Nipah virus--another product from the Asian "virus factory"]Basic Surveillance Network, a European database for surveillance data on infectious diseasesAn outbreak of mumps in Sweden, February-April 2004[Avian influenza--next global infection threat from Asia]Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study.
P50
Q24811910-322B4CB6-10E1-4104-B8EC-00C2426AEF36Q30224649-C8FBE2D4-E578-4372-904A-DADCFA74E860Q30372144-DDE7CBD8-83BC-4A67-ADD4-2BCCD7D8DB64Q30390721-8073F396-475B-4EBF-ABBA-5F6E54D2779EQ30397540-DAF73D16-0A40-4489-B53B-887D617134FBQ30416808-28838AE3-E529-423F-9EDC-FA1857C96C96Q30952744-C8D3C06C-6BF1-4521-B227-945DA57FAE83Q31059061-3B38DEA1-2846-4749-AFDA-E2A4B017AEB4Q33237086-42D53DCA-9460-46E7-8BE2-BA0B2430EAD3Q33298467-92A4E06A-CB81-41AB-8A5D-7E408D149605Q33357073-DD4CD2D3-FB8E-4DD9-961C-D177468A915FQ33395221-EE2D300A-5D10-45C1-8DB2-285C00D71471Q33553253-B4EDB015-5722-435F-A81D-21E7F154555CQ37623582-36356DB3-9BF2-47F5-A3B0-B572CB58F32BQ38302221-E7EBF760-0601-4966-8565-602000AED60AQ39570500-C4CC544B-4339-4F7D-8B8B-1E9C9621C4FCQ39697811-803EFE65-CE6D-4402-AEFB-2851CBBA64F0Q39741620-D9E1F91A-7A57-406F-BD23-DDD90413D929Q41474328-BBA156E6-C35B-4F37-A980-85D8387BA106Q42174715-E25AC191-4544-4349-B86E-869EC90C5669Q42229321-F0F6BC65-EE1E-4964-B1B1-2119EAA96629Q42245526-D66A708D-7D5D-40C8-B89D-723A3A741536Q42315555-6566EB45-7B45-42AB-8BC0-27E2DB4D9276Q42381241-EBF07102-B6CD-4C8A-968F-87A8FDE543F0Q42381529-7B0DD830-56C2-4EBC-9A30-49E5623AFD66Q42924849-1740FC23-5CBE-4B4B-9506-F4610FA99FB4Q47153408-A373F97F-CBC1-4E7A-8440-FCDED430DEC3Q50061130-F0B02381-2F10-484C-8D25-94B0231F27EFQ51093021-1C2C9C0B-0614-4592-89AD-4A83DC5E75E5Q51623550-66ECDD2B-E521-47E4-B1D7-AF0E108C99DEQ56552220-999B1ED6-674E-406E-9807-44F5690630DCQ56897711-D736370A-59DD-4E79-B381-C1254A0ED43FQ57103387-B224D096-BC5E-449B-BD8F-79D7C681073AQ58647405-A95B9EBE-361C-4D4E-A8F2-588286E1A436Q64962925-334914B7-EC8B-41AC-9C9D-931A4422E84F
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Pasi M Penttinen
@ast
Pasi M Penttinen
@en
Pasi M Penttinen
@es
Pasi M Penttinen
@nl
Pasi M Penttinen
@sl
type
label
Pasi M Penttinen
@ast
Pasi M Penttinen
@en
Pasi M Penttinen
@es
Pasi M Penttinen
@nl
Pasi M Penttinen
@sl
prefLabel
Pasi M Penttinen
@ast
Pasi M Penttinen
@en
Pasi M Penttinen
@es
Pasi M Penttinen
@nl
Pasi M Penttinen
@sl
P106
P21
P31
P496
0000-0001-6929-1086
P569
2000-01-01T00:00:00Z